The final amount owed by patients may be as little as $0, but may vary depending on the patient's health insurance plan. Eligible commercially insured patients who are prescribed XOLAIR for an FDA-approved use can receive up to $15,000 in assistance annually for drug costs and/or up to $1,500 in assistance annually for injection costs. For more information, see full program Terms and Conditions.